Optimus Pharma gets DCGI gesture to lead Phase-3 preliminary of COVID-19 antiviral drug Kumar Jeetendra | May 19, 2021 The orally administered drug is being tested for treating mild and moderate infection Optimus Pharma has obtained the approval of the Drug Controller General of India (DCGI) to conduct Phase III clinical trials of orally administered Molnupiravir capsules on patients with mild and moderate Covid-19 infection. In accordance with the clinical trial protocols approved, a …
